Leung, Kin-Mei <br/><br/>
A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  Nov 2015 
 - 1722-1733 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1525-0024 
<br/><br/><label>Standard No.: </label>10.1038/mt.2015.127  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Cell Proliferation<br/>Humans<br/>Immunoglobulin Fc Fragments--pharmacology<br/>MCF-7 Cells<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neoplasms--drug therapy<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Signal Transduction<br/>Trastuzumab--pharmacology<br/>Xenograft Model Antitumor Assays